13,223
Views
100
CrossRef citations to date
0
Altmetric
Review

Irritable bowel syndrome, the microbiota and the gut-brain axis

, , &
Pages 365-383 | Received 11 May 2016, Accepted 26 Jul 2016, Published online: 18 Aug 2016

References

  • Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 2009; 136:2003-14; PMID:19457424; http://dx.doi.org/10.1053/j.gastro.2009.01.075
  • Grenham S, Clarke G, Cryan JF, Dinan TG. Brain-gut-microbe communication in health and disease. Front Physiol 2011; 2:94; PMID:22162969; http://dx.doi.org/10.3389/fphys.2011.00094
  • Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009; 6:306-14; PMID:19404271; http://dx.doi.org/10.1038/nrgastro.2009.35
  • Kennedy PJ, Cryan JF, Dinan TG, Clarke G. Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol 2014; 20:14105-25; PMID:25339800; http://dx.doi.org/10.3748/wjg.v20.i39.14105
  • Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol 2014; 6:71-80; PMID:24523597
  • Rajilić-Stojanović M, Jonkers DM, Salonen A, Hanevik K, Raes J, Jalanka J, de Vos WM, Manichanh C, Golic N, Enck P, et al. Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol 2015; 110:278-87; PMID:25623659; http://dx.doi.org/10.1038/ajg.2014.427
  • Houghton LA, Lea R, Agrawal A, Agrawal A, Reilly B, Whorwell PJ. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit. Gastroenterology 2006; 131:1003-10; PMID:17030170; http://dx.doi.org/10.1053/j.gastro.2006.07.015
  • Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 2015; 28:203-9; PMID:25830558
  • Schwille-Kiuntke J, Mazurak N, Enck P. Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers' diarrhoea. Aliment Pharmacol Ther 2015; 41:1029-37; PMID:25871571; http://dx.doi.org/10.1111/apt.13199
  • Mooney PD, Hayman J, Pickering G, Sanders DS. Are we underestimating the prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome? Neurogastroenterol Motil 2015; 27:1190-1; PMID:26220648; http://dx.doi.org/10.1111/nmo.12573
  • Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis 2015; 26:26191; PMID:25651997
  • Paré P, Gray J, Lam S, Balshaw R, Khorasheh S, Barbeau M, Kelly S, McBurney CR. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Clin Ther 2006; 28:1726-35; discussion 1710-1; PMID:17157129; http://dx.doi.org/10.1016/j.clinthera.2006.10.010
  • American College of Gastroenterology Task Force on Irritable Bowel Syndrome, Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EMM. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104 Suppl:S1-35; PMID:19521341
  • Holzer P, Farzi A. Neuropeptides and the microbiota-gut-brain axis. Adv Exp Med Biol 2014; 817:195-219; PMID:24997035; http://dx.doi.org/10.1007/978-1-4939-0897-4_9
  • Spiegel B, Harris L, Lucak S, Meyer E, Naliboff B, Bolus R, Esrailian E, Chey WD, Lembo AJ, Karsan H, et al. Predictors of Work Productivity in Irritable Bowel Syndrome (IBS): Results from the Proof Cohort. Gastroenterology 2008; 134:A-28
  • Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995; 109:1736-41; PMID:7498636; http://dx.doi.org/10.1016/0016-5085(95)90738-6
  • Longstreth GF, Wilson A, Knight K, Wong J, Chiou C-F, Barghout V, Frech F, Ofman JJ. Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterol 2003; 98:600-7; PMID:12650794
  • Yamamoto R, Kaneita Y, Osaki Y, Kanda H, Suzuki K, Higuchi S, Ikeda M, Kondo S, Munezawa T, Ohida T. Irritable bowel syndrome among Japanese adolescents: A nationally representative survey. J Gastroenterol Hepatol 2015; 30:1354-60; PMID:25868086; http://dx.doi.org/10.1111/jgh.12974
  • Ruigómez A, García Rodríguez LA, Panés J. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities. Clin Gastroenterol Hepatol 2007; 5:465-9; PMID:17445753; http://dx.doi.org/10.1016/j.cgh.2007.02.008
  • Clarke G, Quigley EMM, Cryan JF, Dinan TG. Irritable bowel syndrome: towards biomarker identification. Trends Mol Med 2009; 15:478-89; PMID:19811951; http://dx.doi.org/10.1016/j.molmed.2009.08.001
  • Greer JB, O'Keefe SJ. Microbial induction of immunity, inflammation, and cancer. Front Physiol 2011; 1:168; PMID:21423403; http://dx.doi.org/10.3389/fphys.2010.00168
  • Wu SV, Hui H. Treat your bug right. Front Physiol 2011; 2:9; PMID:21483729; http://dx.doi.org/10.3389/fphys.2011.00009
  • Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol 2012; 107:991-1000; PMID:22613905; http://dx.doi.org/10.1038/ajg.2012.131
  • van den Wijngaard RM, Stanisor OI, van Diest SA, Welting O, Wouters MM, Cailotto C, de Jonge WJ, Boeckxstaens GE. Susceptibility to stress induced visceral hypersensitivity in maternally separated rats is transferred across generations. Neurogastroenterol Motil 2013; 25:e780-90; PMID:23965154; http://dx.doi.org/10.1111/nmo.12202
  • Hyland NP, O'Mahony SM, O'Malley D, O'Mahony CM, Dinan TG, Cryan JF. Early-life stress selectively affects gastrointestinal but not behavioral responses in a genetic model of brain-gut axis dysfunction. Neurogastroenterol Motil 2015; 27:105-13; PMID:25443141; http://dx.doi.org/10.1111/nmo.12486
  • Barouei J, Moussavi M, Hodgson DM. Effect of maternal probiotic intervention on HPA axis, immunity and gut microbiota in a rat model of irritable bowel syndrome. PLoS One 2012; 7:e46051; PMID:23071537; http://dx.doi.org/10.1371/journal.pone.0046051
  • De Palma G, Blennerhassett P, Lu J, Deng Y, Park AJ, Green W, Denou E, Silva MA, Santacruz A, Sanz Y, et al. Microbiota and host determinants of behavioural phenotype in maternally separated mice. Nat Commun 2015; 6:7735; PMID:26218677; http://dx.doi.org/10.1038/ncomms8735
  • Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65; PMID:20203603; http://dx.doi.org/10.1038/nature08821
  • Maukonen J, Saarela M. Human gut microbiota: does diet matter? Proc Nutr Soc 2015; 74:23-36; PMID:25156389; http://dx.doi.org/10.1017/S0029665114000688
  • Plaza-Diaz J, Gomez-Llorente C, Fontana L, Gil A. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics. World J Gastroenterol 2014; 20:15632-49; PMID:25400447; http://dx.doi.org/10.3748/wjg.v20.i42.15632
  • Gritz EC, Bhandari V. The human neonatal gut microbiome: a brief review. Front Pediatr 2015; 3:17; PMID:25798435
  • Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124:837-48; PMID:16497592; http://dx.doi.org/10.1016/j.cell.2006.02.017
  • Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012; 148:1258-70; PMID:22424233; http://dx.doi.org/10.1016/j.cell.2012.01.035
  • Xu J, Mahowald MA, Ley RE, Lozupone CA, Hamady M, Martens EC, Henrissat B, Coutinho PM, Minx P, Latreille P, et al. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol 2007; 5:e156; PMID:17579514; http://dx.doi.org/10.1371/journal.pbio.0050156
  • Rajilić-Stojanović M, Smidt H, de Vos WM. Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol 2007; 9:2125-36; PMID:17686012; http://dx.doi.org/10.1111/j.1462-2920.2007.01369.x
  • Zoetendal EG, Rajilic-Stojanovic M, de Vos WM. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008; 57:1605-15; PMID:18941009; http://dx.doi.org/10.1136/gut.2007.133603
  • Hugon P, Lagier J-C, Robert C, Lepolard C, Papazian L, Musso D, Vialettes B, Raoult D. Molecular studies neglect apparently gram-negative populations in the human gut microbiota. J Clin Microbiol 2013; 51:3286-93; PMID:23885002; http://dx.doi.org/10.1128/JCM.00473-13
  • Dominguez-Bello MG, Blaser MJ, Ley RE, Knight R. Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology 2011; 140:1713-9; PMID:21530737; http://dx.doi.org/10.1053/j.gastro.2011.02.011
  • Abdallah Ismail N, Ragab SH, Abd Elbaky A, Shoeib ARS, Alhosary Y, Fekry D. Frequency of Firmicutes and Bacteroidetes in gut microbiota in obese and normal weight Egyptian children and adults. Arch Med Sci 2011; 7:501-7; PMID:22295035; http://dx.doi.org/10.5114/aoms.2011.23418
  • Parthasarathy G, Chen J, Chen X, Chia N, O'Connor HM, Wolf PG, Gaskins HR, Bharucha AE. Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation. Gastroenterology 2016; 150:367-79; PMID:26460205; http://dx.doi.org/10.1053/j.gastro.2015.10.005
  • Raskov H, Pommergaard H-C, Burcharth J, Rosenberg J. Colorectal carcinogenesis-update and perspectives. World J Gastroenterol 2014; 20:18151-64; PMID:25561783; http://dx.doi.org/10.3748/wjg.v20.i48.18151
  • Winter SE, Bäumler AJ. Dysbiosis in the inflamed intestine: chance favors the prepared microbe. Gut Microbes 5:71-3; PMID:24637596; http://dx.doi.org/10.4161/gmic.27129
  • Hong SN, Rhee P-L. Unraveling the ties between irritable bowel syndrome and intestinal microbiota. World J Gastroenterol 2014; 20:2470-81; PMID:24627584; http://dx.doi.org/10.3748/wjg.v20.i10.2470
  • Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science 2005; 308:1635-8; PMID:15831718; http://dx.doi.org/10.1126/science.1110591
  • Del Chierico F, Vernocchi P, Petrucca A, Paci P, Fuentes S, Praticò G, Capuani G, Masotti A, Reddel S, Russo A, et al. Phylogenetic and Metabolic Tracking of Gut Microbiota during Perinatal Development. PLoS One 2015; 10:e0137347; PMID:26332837
  • Saulnier DM, Ringel Y, Heyman MB, Foster JA, Bercik P, Shulman RJ, Versalovic J, Verdu EF, Dinan TG, Hecht G, et al. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes 4:17-27; PMID:23202796; http://dx.doi.org/10.4161/gmic.22973
  • Mueller NT, Bakacs E, Combellick J, Grigoryan Z, Dominguez-Bello MG. The infant microbiome development: mom matters. Trends Mol Med 2015; 21:109-17; PMID:25578246; http://dx.doi.org/10.1016/j.molmed.2014.12.002
  • Madan JC, Farzan SF, Hibberd PL, Karagas MR. Normal neonatal microbiome variation in relation to environmental factors, infection and allergy. Curr Opin Pediatr 2012; 24:753-9; PMID:23111681; http://dx.doi.org/10.1097/MOP.0b013e32835a1ac8
  • Di Mauro A, Neu J, Riezzo G, Raimondi F, Martinelli D, Francavilla R, Indrio F. Gastrointestinal function development and microbiota. Ital J Pediatr 2013; 39:15; PMID:23433508; http://dx.doi.org/10.1186/1824-7288-39-15
  • Torrazza RM, Neu J. The altered gut microbiome and necrotizing enterocolitis. Clin Perinatol 2013; 40:93-108; PMID:23415266; http://dx.doi.org/10.1016/j.clp.2012.12.009
  • Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med 2014; 6:237ra65
  • Solís G, de Los Reyes-Gavilan CG, Fernández N, Margolles A, Gueimonde M. Establishment and development of lactic acid bacteria and bifidobacteria microbiota in breast-milk and the infant gut. Anaerobe 2010; 16:307-10; PMID:20176122; http://dx.doi.org/10.1016/j.anaerobe.2010.02.004
  • Jost T, Lacroix C, Braegger C, Chassard C. Impact of human milk bacteria and oligosaccharides on neonatal gut microbiota establishment and gut health. Nutr Rev 2015; 73:426-37; PMID:26081453; http://dx.doi.org/10.1093/nutrit/nuu016
  • Parigi SM, Eldh M, Larssen P, Gabrielsson S, Villablanca EJ. Breast Milk and Solid Food Shaping Intestinal Immunity. Front Immunol 2015; 6:415; PMID:26347740; http://dx.doi.org/10.3389/fimmu.2015.00415
  • Cabrera-Rubio R, Mira-Pascual L, Mira A, Collado MC. Impact of mode of delivery on the milk microbiota composition of healthy women. J Dev Orig Health Dis 2016; 7:54-60; PMID:26286040; http://dx.doi.org/10.1017/S2040174415001397
  • Civardi E, Garofoli F, Tzialla C, Paolillo P, Bollani L, Stronati M. Microorganisms in human milk: lights and shadows. J Matern Fetal Neonatal Med 2013; 2 26 Suppl:30-4; PMID:24059550; http://dx.doi.org/10.3109/14767058.2013.829693
  • Casén C, Vebø HC, Sekelja M, Hegge FT, Karlsson MK, Ciemniejewska E, Dzankovic S, Frøyland C, Nestestog R, Engstrand L, et al. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Aliment Pharmacol Ther 2015; 42:71-83; PMID:25973666; http://dx.doi.org/10.1111/apt.13236
  • Bennet SMP, Ohman L, Simren M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver 2015; 9:318-31; PMID:25918261; http://dx.doi.org/10.5009/gnl14344
  • Parkes GC, Rayment NB, Hudspith BN, Petrovska L, Lomer MC, Brostoff J, Whelan K, Sanderson JD. Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome. Neurogastroenterol Motil 2012; 24:31-9; PMID:22070725; http://dx.doi.org/10.1111/j.1365-2982.2011.01803.x
  • Rajilić-Stojanović M, Biagi E, Heilig HGHJ, Kajander K, Kekkonen RA, Tims S, de Vos WM. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011; 141:1792-801; PMID:21820992; http://dx.doi.org/10.1053/j.gastro.2011.07.043
  • Jalanka-Tuovinen J, Salonen A, Nikkilä J, Immonen O, Kekkonen R, Lahti L, Palva A, de Vos WM. Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS One 2011; 6:e23035; PMID:21829582
  • Rinttilä T, Lyra A, Krogius-Kurikka L, Palva A. Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects. Gut Pathog 2011; 3:6; PMID:21518462; http://dx.doi.org/10.1186/1757-4749-3-6
  • Schwille-Kiuntke J, Enck P, Zendler C, Krieg M, Polster AV, Klosterhalfen S, Autenrieth IB, Zipfel S, Frick JS. Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter. Neurogastroenterol Motil 2011; 23:e479-88; PMID:21883703; http://dx.doi.org/10.1111/j.1365-2982.2011.01779.x
  • Jeffery IB, O'Toole PW, Öhman L, Claesson MJ, Deane J, Quigley EM, Simrén M. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut. 2012; 61:997-1006; PMID:22180058; http://dx.doi.org/10.1136/gutjnl-2011-301501
  • Ringel Y, Ringel-Kulka T. The Intestinal Microbiota and Irritable Bowel Syndrome. J Clin Gastroenterol 49 Suppl 1:S56-9; PMID:26447966
  • Lee KN, Lee OY. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J Gastroenterol 2014; 20:8886-97; PMID:25083061
  • Sundin J, Rangel I, Kumawat AK, Hultgren-Hörnquist E, Brummer RJ. Aberrant mucosal lymphocyte number and subsets in the colon of post-infectious irritable bowel syndrome patients. Scand J Gastroenterol 2014; 49:1068-75; PMID:24919810; http://dx.doi.org/10.3109/00365521.2014.926982
  • Wouters MM, Vicario M, Santos J. The role of mast cells in functional GI disorders. Gut 2016; 65:155-68; PMID:26194403; http://dx.doi.org/10.1136/gutjnl-2015-309151
  • de Kivit S, Tobin MC, Forsyth CB, Keshavarzian A, Landay AL. Regulation of Intestinal Immune Responses through TLR Activation: Implications for Pro- and Prebiotics. Front Immunol 2014; 5:60; PMID:24600450; http://dx.doi.org/10.3389/fimmu.2014.00060
  • Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke J-D, Serino M, Tilg H, Watson A, Wells JM. Intestinal permeability-a new target for disease prevention and therapy. BMC Gastroenterol 2014; 14:189; PMID:25407511; http://dx.doi.org/10.1186/s12876-014-0189-7
  • Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9:46-56; PMID:18073775; http://dx.doi.org/10.1038/nrn2297
  • Piche T. Tight junctions and IBS-the link between epithelial permeability, low-grade inflammation, and symptom generation? Neurogastroenterol Motil 2014; 26:296-302; PMID:24548256; http://dx.doi.org/10.1111/nmo.12315
  • Hashimoto D, Miller J, Merad M. Dendritic cell and macrophage heterogeneity in vivo. Immunity 2011; 35:323-35; PMID:21943488; http://dx.doi.org/10.1016/j.immuni.2011.09.007
  • Mikkelsen HB. Interstitial cells of Cajal, macrophages and mast cells in the gut musculature: morphology, distribution, spatial and possible functional interactions. J Cell Mol Med. 2010; 14:818-32; PMID:20132411; http://dx.doi.org/10.1111/j.1582-4934.2010.01025.x
  • Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M, Becker CD, See P, Price J, Lucas D, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 2013; 38:792-804; PMID:23601688; http://dx.doi.org/10.1016/j.immuni.2013.04.004
  • Anitha M, Vijay-Kumar M, Sitaraman SV, Gewirtz AT, Srinivasan S. Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling. Gastroenterology 2012; 143:1006-16; PMID:22732731; http://dx.doi.org/10.1053/j.gastro.2012.06.034
  • Martínez C, Vicario M, Ramos L, Lobo B, Mosquera JL, Alonso C, Sánchez A, Guilarte M, Antolín M, de Torres I, et al. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations. Am J Gastroenterol 2012; 107:736-46; PMID:22415197; http://dx.doi.org/10.1038/ajg.2011.472
  • Wilcz-Villega E, McClean S, O'sullivan M. Reduced E-cadherin expression is associated with abdominal pain and symptom duration in a study of alternating and diarrhea predominant IBS. Neurogastroenterol Motil 2014; 26:316-25; PMID:24286617; http://dx.doi.org/10.1111/nmo.12262
  • Martínez C, Lobo B, Pigrau M, Ramos L, González-Castro AM, Alonso C, Guilarte M, Guilá M, de Torres I, Azpiroz F, et al. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut 2013; 62:1160-8; PMID:22637702; http://dx.doi.org/10.1136/gutjnl-2012-302093
  • Mart??nez C, Gonz??lez-Castro A, Vicario M, Santos J. Cellular and molecular basis of intestinal barrier dysfunction in the irritable bowel syndrome. Gut Liver 2012; 6:305-15; PMID:22844557; http://dx.doi.org/10.5009/gnl.2012.6.3.305
  • Elsenbruch S. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun 2011; 25:386-94; PMID:21094682; http://dx.doi.org/10.1016/j.bbi.2010.11.010
  • Vermeulen W, De Man JG, Pelckmans PA, De Winter BY. Neuroanatomy of lower gastrointestinal pain disorders. World J Gastroenterol 2014; 20:1005-20; PMID:24574773; http://dx.doi.org/10.3748/wjg.v20.i4.1005
  • Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, De Giorgio R, Stanghellini V, Corinaldesi R, Barbara G. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 2009; 104:392-400; PMID:19174797; http://dx.doi.org/10.1038/ajg.2008.94
  • Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126:693-702; PMID:14988823; http://dx.doi.org/10.1053/j.gastro.2003.11.055
  • Ishihara S, Tada Y, Fukuba N, Oka A, Kusunoki R, Mishima Y, Oshima N, Moriyama I, Yuki T, Kawashima K, et al. Pathogenesis of irritable bowel syndrome-review regarding associated infection and immune activation. Digestion 2013; 87:204-11; PMID:23712295; http://dx.doi.org/10.1159/000350054
  • Monsbakken KW, Vandvik PO, Farup PG. Perceived food intolerance in subjects with irritable bowel syndrome- etiology, prevalence and consequences. Eur J Clin Nutr 2006; 60:667-72; PMID:16391571; http://dx.doi.org/10.1038/sj.ejcn.1602367
  • Simrén M, Månsson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U, Björnsson ES. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 2001; 63:108-15; PMID:11244249; http://dx.doi.org/10.1159/000051878
  • Hayes PA, Fraher MH, Quigley EMM. Irritable bowel syndrome: the role of food in pathogenesis and management. Gastroenterol Hepatol (N Y) 2014; 10:164-74; PMID:24829543
  • Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr 2015; 55:897-906; PMID:25982757; PMID:25982757
  • Molina-Infante J, Serra J, Fernandez-Bañares F, Mearin F. The low-FODMAP diet for irritable bowel syndrome: Lights and shadows. Gastroenterol Hepatol 2015; 39:55-65; PMID:26548734; http://dx.doi.org/10.1016/j.gastrohep.2015.07.009
  • Staudacher HM, Lomer MCE, Anderson JL, Barrett JS, Muir JG, Irving PM, Whelan K. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012; 142:1510-8; PMID:22739368; http://dx.doi.org/10.3945/jn.112.159285
  • Shepherd SJ, Parker FC, Muir JG, Gibson PR. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008; 6:765-71; PMID:18456565; http://dx.doi.org/10.1016/j.cgh.2008.02.058
  • Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Gibson PR, Muir JG. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015; 64:93-100; PMID:25016597; http://dx.doi.org/10.1136/gutjnl-2014-307264
  • Manichanh C, Eck A, Varela E, Roca J, Clemente JC, González A, Knights D, Knight R, Estrella S, Hernandez C, et al. Anal gas evacuation and colonic microbiota in patients with flatulence: effect of diet. Gut 2014; 63:401-8; PMID:23766444; http://dx.doi.org/10.1136/gutjnl-2012-303013
  • Chumpitazi BP, Hollister EB, Oezguen N, Tsai CM, McMeans AR, Luna RA, Savidge TC, Versalovic J, Shulman RJ. Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome. Gut Microbes 5:165-75; PMID:24637601; http://dx.doi.org/10.4161/gmic.27923
  • Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014; 146:67-75; PMID:24076059; http://dx.doi.org/10.1053/j.gastro.2013.09.046
  • Spiller R. Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Res 2016; 5. Faculty Rev-780; PMID:27158477; http://dx.doi.org/10.12688/f1000research.7992.1
  • Hookway C, Buckner S, Crosland P, Longson D. Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance. BMJ 2015; 350:h701; PMID:25716701; http://dx.doi.org/10.1136/bmj.h701
  • Camilleri M. Bile Acid diarrhea: prevalence, pathogenesis, and therapy. Gut Liver 2015; 9:332-9; PMID:25918262; http://dx.doi.org/10.5009/gnl14397
  • Appleby RN, Walters JR. The role of bile acids in functional GI disorders. Neurogastroenterol Motil 2014; 26:1057-69; PMID:24898156; http://dx.doi.org/10.1111/nmo.12370
  • Duboc H, Rainteau D, Rajca S, Humbert L, Farabos D, Maubert M, Grondin V, Jouet P, Bouhassira D, Seksik P, et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 2012; 24:513-20; PMID:22356587; http://dx.doi.org/10.1111/j.1365-2982.2012.01893.x
  • Qin H-Y, Cheng C-W, Tang X-D, Bian Z-X. Impact of psychological stress on irritable bowel syndrome. World J Gastroenterol 2014; 20:14126-31; PMID:25339801; http://dx.doi.org/10.3748/wjg.v20.i39.14126
  • Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest 2015; 125:926-38; PMID:25689247; http://dx.doi.org/10.1172/JCI76304
  • Xu F, Wu C, Guo F, Cui G, Zeng X, Yang B, Lin J. Transcriptomic analysis of Campylobacter jejuni NCTC 11168 in response to epinephrine and norepinephrine. Front Microbiol 2015; 6:452; PMID:26042101
  • Pigrau M, Rodiño-Janeiro BK, Casado-Bedmar M, Lobo B, Vicario M, Santos J, Alonso-Cotoner C. The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome. Neurogastroenterol Motil 2016; 28:463-86; PMID:26556786; http://dx.doi.org/10.1111/nmo.12717
  • Dinan TG, Cryan JF. Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendocrinology 2012; 37:1369-78; PMID:22483040; http://dx.doi.org/10.1016/j.psyneuen.2012.03.007
  • Linnman C. New pieces for the substance P puzzle. Pain 2013; 154:966-7; PMID:23643331; http://dx.doi.org/10.1016/j.pain.2013.04.020
  • Al-Qudah M, Alkahtani R, Akbarali HI, Murthy KS, Grider JR. Stimulation of synthesis and release of brain-derived neurotropic factor from intestinal smooth muscle cells by substance P and pituitary adenylate cyclase-activating peptide. Neurogastroenterol Motil 2015; 27:1162-74; PMID:26088546; http://dx.doi.org/10.1111/nmo.12604
  • Morowitz MJ, Babrowski T, Carlisle EM, Olivas A, Romanowski KS, Seal JB, Liu DC, Alverdy JC. The human microbiome and surgical disease. Ann Surg 2011; 253:1094-101; PMID:21422915; http://dx.doi.org/10.1097/SLA.0b013e31821175d7
  • Ben-Israel Y, Shadach E, Levy S, Sperber A, Aizenberg D, Niv Y, Dickman R. Possible Involvement of Avoidant Attachment Style in the Relations Between Adult IBS and Reported Separation Anxiety in Childhood. Stress Health 2016; in press; PMID:26033751
  • WHO. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food, London, Ontario, Canada, 30 April-1 May 2002. WHO and FAO Organization of the United Nations ISBN 9251055130. 2002.
  • EFSA [Internet]. Available from: http://www.efsa.europa.eu/en/topics/topic/nutrition
  • Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature 2012; 489:231-41; PMID:22972296; http://dx.doi.org/10.1038/nature11551
  • Jain N, Walker WA. Diet and host-microbial crosstalk in postnatal intestinal immune homeostasis. Nat Rev Gastroenterol Hepatol 2015; 12:14-25; PMID:25201040; http://dx.doi.org/10.1038/nrgastro.2014.153
  • Rao RK, Samak G. Protection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical Implications. Curr Nutr Food Sci 2013; 9:99-107; PMID:24353483; http://dx.doi.org/10.2174/1573401311309020004
  • Nébot-Vivinus M, Harkat C, Bzioueche H, Cartier C, Plichon-Dainese R, Moussa L, Eutamene H, Pishvaie D, Holowacz S, Seyrig C, et al. Multispecies probiotic protects gut barrier function in experimental models. World J Gastroenterol 2014; 20:6832-43; PMID:24944474; http://dx.doi.org/10.3748/wjg.v20.i22.6832
  • Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis 2015; 60 Suppl 2:S129-34; PMID:25922398; http://dx.doi.org/10.1093/cid/civ085
  • Hill C, Sanders ME. Rethinking “probiotics”. Gut Microbes 2013; 4:269-70; PMID:23778363; http://dx.doi.org/10.4161/gmic.25143
  • Ritchie ML, Romanuk TN. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 2012; 7:e34938; PMID:22529959; http://dx.doi.org/10.1371/journal.pone.0034938
  • Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, Zoetendal EG, de Vos WM, Vapaatalo H, et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther 2008; 27:48-57; PMID:17919270; http://dx.doi.org/10.1111/j.1365-2036.2007.03542.x
  • Ford AC, Quigley EMM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BMR, Moayyedi P. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 2014; 109:1547-61; quiz 1546, 1562; PMID:25070051; http://dx.doi.org/10.1038/ajg.2014.202
  • Gritz EC, Bhandari V. Corrigendum: The Human Neonatal Gut Microbiome: A Brief Review. Front Pediatr 2015; 3:60; PMID:26176006
  • Aguilera M, Cerdà-Cuéllar M, Martínez V. Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice. Gut Microbes 2015; 6:10-23; PMID:25531553; http://dx.doi.org/10.4161/19490976.2014.990790
  • Korpela R, Niittynen L. Probiotics and irritable bowel syndrome. Microb Ecol Health Dis 2012; 23; PMID:23990830
  • Steenbergen L, Sellaro R, van Hemert S, Bosch JA, Colzato LS. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun 2015; 48:258-64; PMID:25862297; http://dx.doi.org/10.1016/j.bbi.2015.04.003
  • Messaoudi M, Violle N, Bisson J-F, Desor D, Javelot H, Rougeot C. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes 2011; 2:256-61; PMID:21983070; http://dx.doi.org/10.4161/gmic.2.4.16108
  • Bravo JA, Julio-Pieper M, Forsythe P, Kunze W, Dinan TG, Bienenstock J, Cryan JF. Communication between gastrointestinal bacteria and the nervous system. Curr Opin Pharmacol 2012; 12:667-72; PMID:23041079; http://dx.doi.org/10.1016/j.coph.2012.09.010
  • El Aidy S, Stilling R, Dinan TG, Cryan JF. Microbiome to Brain: Unravelling the Multidirectional Axes of Communication. Adv Exp Med Biol 2016; 874:301-36; PMID:26589226
  • Mayer EA, Savidge T, Shulman RJ. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology 2014; 146:1500-12; PMID:24583088; http://dx.doi.org/10.1053/j.gastro.2014.02.037
  • Reigstad CS, Salmonson CE, Rainey JF 3rd, Szurszewski JH, Linden DR, Sonnenburg JL, Farrugia G, Kashyap PC. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J 2015; 29:1395-403; PMID:25550456; http://dx.doi.org/10.1096/fj.14-259598
  • Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 2015; 161:264-76. Erratum in: Cell 2015;163:258; PMID:25860609; http://dx.doi.org/10.1016/j.cell.2015.02.047
  • Li Z, Chalazonitis A, Huang Y-Y, Mann JJ, Margolis KG, Yang QM, Kim DO, Côté F, Mallet J, Gershon MD. Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons. J Neurosci 2011; 31:8998-9009; PMID:21677183; http://dx.doi.org/10.1523/JNEUROSCI.6684-10.2011
  • Furness JB, Callaghan BP, Rivera LR, Cho H-J. The enteric nervous system and gastrointestinal innervation: integrated local and central control. Adv Exp Med Biol 2014; 817:39-71; PMID:24997029; http://dx.doi.org/10.1007/978-1-4939-0897-4_3
  • Posserud I, Syrous A, Lindström L, Tack J, Abrahamsson H, Simrén M. Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology 2007; 133:1113-23; PMID:17919487; http://dx.doi.org/10.1053/j.gastro.2007.07.024
  • Kamm K, Hoppe S, Breves G, Schröder B, Schemann M. Effects of the probiotic yeast Saccharomyces boulardii on the neurochemistry of myenteric neurones in pig jejunum. Neurogastroenterol Motil 2004; 16:53-60; PMID:14764205; http://dx.doi.org/10.1046/j.1365-2982.2003.00458.x
  • Wang XM, Liu YL. Signal transduction pathway of colonic Toll-like receptor 4 in patients with irritable bowel syndrome. Zhonghua Yi Xue Za Zhi 2008; 88:3415-7; PMID:19159572
  • Brint EK, MacSharry J, Fanning A, Shanahan F, Quigley EM. Differential expression of toll-like receptors in patients with irritable bowel syndrome. Am J Gastroenterol 2011; 106:329-36; PMID:21102570; http://dx.doi.org/10.1038/ajg.2010.438
  • Overhaus M, Tögel S, Pezzone MA, Bauer AJ. Mechanisms of polymicrobial sepsis-induced ileus. Am J Physiol Gastrointest Liver Physiol 2004; 287:G685-94; PMID:15331356; http://dx.doi.org/10.1152/ajpgi.00359.2003
  • Grundy D. Neuroanatomy of visceral nociception: vagal and splanchnic afferent. Gut 2002; 51 Suppl 1:i2-5; PMID:12077054; http://dx.doi.org/10.1136/gut.51.suppl_1.i2
  • Adeghate E, Ponery AS. GABA in the endocrine pancreas: cellular localization and function in normal and diabetic rats. Tissue Cell 2002; 34:1-6; PMID:11989965; http://dx.doi.org/10.1054/tice.2002.0217
  • Roth FC, Draguhn A. GABA metabolism and transport: effects on synaptic efficacy. Neural Plast 2012; 805830; PMID:22530158
  • Ravnefjord A, Brusberg M, Larsson H, Lindström E, Martínez V. Effects of pregabalin on visceral pain responses and colonic compliance in rats. Br J Pharmacol 2008; 155:407-16; PMID:18574457; http://dx.doi.org/10.1038/bjp.2008.259
  • Zhang MM, Liu SB, Chen T, Koga K, Zhang T, Li YQ, Zhuo M. Effects of NB001 and gabapentin on irritable bowel syndrome-induced behavioral anxiety and spontaneous pain. Mol Brain 2014; 7:47; PMID:24935250; http://dx.doi.org/10.1186/1756-6606-7-47
  • Moloney RD, O'Mahony SM, Dinan TG, Cryan JF. Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities. Front Psychiatry 2015; 6:15; PMID:25762939; http://dx.doi.org/10.3389/fpsyt.2015.00015
  • Barrett E, Ross RP, O'Toole PW, Fitzgerald GF, Stanton C. γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 2012; 113:411-7; PMID:22612585; http://dx.doi.org/10.1111/j.1365-2672.2012.05344.x
  • Dhakal R, Bajpai VK, Baek KH. Production of gaba (γ - Aminobutyric acid) by microorganisms: a review. Braz J Microbiol 2012; 43:1230-41; PMID:24031948; http://dx.doi.org/10.1590/S1517-83822012000400001
  • Hyland NP, Golubeva AV. GABA(B) receptors in the bladder and bowel: Therapeutic potential for positive allosteric modulators? Br J Pharmacol 2016; in press
  • Greenwood-Van Meerveld B, Moloney RD, Johnson AC, Vicario M. Mechanisms of stress-induced visceral pain: implications in irritable bowel syndrome. J Neuroendocrinol 2016; in press; PMID:26749172
  • Garland EL. Pain processing in the human nervous system: a selective review of nociceptive and biobehavioral pathways. Prim Care 2012; 39:561-71; PMID:22958566; http://dx.doi.org/10.1016/j.pop.2012.06.013
  • Riddle MS, Welsh M, Porter CK, Nieh C, Boyko EJ, Gackstetter G, Hooper TI. The Epidemiology of Irritable Bowel Syndrome in the US Military: Findings from the Millennium Cohort Study. Am J Gastroenterol 2016; 111:93-104; PMID:26729548; http://dx.doi.org/10.1038/ajg.2015.386
  • Daulatzai MA. Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia. Neurochem Res 2014; 39:624-44; PMID:24590859; http://dx.doi.org/10.1007/s11064-014-1266-6
  • De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, Guerzoni ME, Gobbetti M, Francavilla R. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One 2013; 8:e76993; PMID:24130822; http://dx.doi.org/10.1371/journal.pone.0076993
  • Finegold SM, Molitoris D, Song Y, Liu C, Vaisanen M-L, Bolte E, McTeague M, Sandler R, Wexler H, Marlowe EM, et al. Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 2002; 35:S6-16; PMID:12173102; http://dx.doi.org/10.1086/341914
  • Frye RE, Slattery J, MacFabe DF, Allen-Vercoe E, Parker W, Rodakis J, Adams JB, Krajmalnik-Brown R, Bolte E, Kahler S, et al. Approaches to studying and manipulating the enteric microbiome to improve autism symptoms. Microb Ecol Health Dis 2015; 26:26878; PMID:25956237
  • Browning KN. Protease-activated receptors: novel central role in modulation of gastric functions. Neurogastroenterol Motil 2010; 22:361-5; PMID:20377791; http://dx.doi.org/10.1111/j.1365-2982.2010.01475.x
  • Bailey MT. Influence of stressor-induced nervous system activation on the intestinal microbiota and the importance for immunomodulation. Adv Exp Med Biol 2014; 817:255-76; PMID:24997038; http://dx.doi.org/10.1007/978-1-4939-0897-4_12
  • Moayyedi P, Quigley EMM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BMR, Ford AC. The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol 2014; 109:1367-74; PMID:25070054; http://dx.doi.org/10.1038/ajg.2014.195
  • Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane database Syst Rev 2011; CD003460; PMID:21833945
  • Ford AC, Talley NJ, Spiegel BMR, Foxx-Orenstein AE, Schiller L, Quigley EMM, Moayyedi P. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008; 337:a2313; PMID:19008265; http://dx.doi.org/10.1136/bmj.a2313
  • Khanna R, MacDonald JK, Levesque BG. Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Clin Gastroenterol 2014; 48:505-12; PMID:24100754
  • Martínez-Vázquez MA, Vázquez-Elizondo G, González-González JA, Gutiérrez-Udave R, Maldonado-Garza HJ, Bosques-Padilla FJ. Effect of antispasmodic agents, alone or in combination, in the treatment of Irritable Bowel Syndrome: systematic review and meta-analysis. Rev Gastroenterol México 2012; 77:82-90; PMID:22672854; http://dx.doi.org/10.1016/j.rgmx.2012.04.002
  • Wittmann T, Paradowski L, Ducrotté P, Bueno L, Andro Delestrain M-C. Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome-a randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther 2010; 31:615-24
  • Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther 2002; 16:1641-8; PMID:20003095; PMID:12197843; http://dx.doi.org/10.1046/j.1365-2036.2002.01322.x
  • van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JFWM, Tijssen JGP, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368:407-15; PMID:23323867; http://dx.doi.org/10.1056/NEJMoa1205037

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.